CA Stock MarketDetailed Quotes

VXL Vaxil Bio Ltd

Watchlist
  • 0.010
  • 0.0000.00%
15min DelayMarket Closed May 22 16:00 ET
1.37MMarket Cap0.00P/E (TTM)

Vaxil Bio Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-53.60%58K
-55.65%259K
-115.03%-26K
-76.26%33K
-13.01%127K
-0.79%125K
-40.77%584K
-38.21%173K
-41.84%139K
-30.14%146K
Selling and administrative expenses
-41.54%38K
-39.33%145K
-157.14%-48K
-36.00%32K
123.26%96K
4.84%65K
-44.16%239K
2.44%84K
-41.86%50K
-62.28%43K
-General and administrative expense
-41.54%38K
-39.33%145K
-157.14%-48K
-36.00%32K
123.26%96K
4.84%65K
-44.16%239K
2.44%84K
-41.86%50K
-62.28%43K
Research and development costs
-66.67%20K
-66.76%114K
-75.28%22K
-98.88%1K
-69.90%31K
-3.23%60K
-36.36%343K
-50.83%89K
-41.45%89K
8.42%103K
Depreciation amortization depletion
----
--0
--0
--0
--0
----
-89.47%2K
--0
--0
--0
-Depreciation and amortization
----
--0
--0
--0
--0
----
-89.47%2K
--0
--0
--0
Operating profit
53.60%-58K
55.65%-259K
115.03%26K
76.26%-33K
13.01%-127K
0.79%-125K
40.77%-584K
38.21%-173K
41.84%-139K
30.14%-146K
Net non-operating interest income (expenses)
Other net income (expenses)
5K
0
5K
Special income (charges)
----
--5K
--0
--5K
----
----
--0
--0
--0
----
-Gain on sale of property,plant,equipment
----
--5K
--0
--5K
----
----
--0
--0
--0
----
Income before tax
53.60%-58K
56.51%-254K
115.03%26K
79.86%-28K
13.01%-127K
0.79%-125K
40.77%-584K
38.21%-173K
41.84%-139K
30.14%-146K
Income tax
Earnings from equity interest net of tax
Net income
53.60%-58K
56.51%-254K
115.03%26K
79.86%-28K
13.01%-127K
0.79%-125K
40.77%-584K
38.21%-173K
41.84%-139K
30.14%-146K
Net income continuous operations
53.60%-58K
56.51%-254K
115.03%26K
79.86%-28K
13.01%-127K
0.79%-125K
40.77%-584K
38.21%-173K
41.84%-139K
30.14%-146K
Noncontrolling interests
Net income attributable to the company
53.60%-58K
56.51%-254K
115.03%26K
79.86%-28K
13.01%-127K
0.79%-125K
40.77%-584K
38.21%-173K
41.84%-139K
30.14%-146K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
53.60%-58K
56.51%-254K
115.03%26K
79.86%-28K
13.01%-127K
0.79%-125K
40.77%-584K
38.21%-173K
41.84%-139K
30.14%-146K
Diluted earnings per share
95.77%-0.0004
0.00%-0.01
-13.66%-0.008
79.90%-0.0002
13.04%-0.0009
-986.96%-0.01
0.00%-0.01
-47.99%-0.007
41.97%-0.001
89.34%-0.0011
Basic earnings per share
95.77%-0.0004
0.00%-0.01
-13.66%-0.008
79.90%-0.0002
13.04%-0.0009
-986.96%-0.01
0.00%-0.01
-47.99%-0.007
41.97%-0.001
89.34%-0.0011
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -53.60%58K-55.65%259K-115.03%-26K-76.26%33K-13.01%127K-0.79%125K-40.77%584K-38.21%173K-41.84%139K-30.14%146K
Selling and administrative expenses -41.54%38K-39.33%145K-157.14%-48K-36.00%32K123.26%96K4.84%65K-44.16%239K2.44%84K-41.86%50K-62.28%43K
-General and administrative expense -41.54%38K-39.33%145K-157.14%-48K-36.00%32K123.26%96K4.84%65K-44.16%239K2.44%84K-41.86%50K-62.28%43K
Research and development costs -66.67%20K-66.76%114K-75.28%22K-98.88%1K-69.90%31K-3.23%60K-36.36%343K-50.83%89K-41.45%89K8.42%103K
Depreciation amortization depletion ------0--0--0--0-----89.47%2K--0--0--0
-Depreciation and amortization ------0--0--0--0-----89.47%2K--0--0--0
Operating profit 53.60%-58K55.65%-259K115.03%26K76.26%-33K13.01%-127K0.79%-125K40.77%-584K38.21%-173K41.84%-139K30.14%-146K
Net non-operating interest income (expenses)
Other net income (expenses) 5K05K
Special income (charges) ------5K--0--5K----------0--0--0----
-Gain on sale of property,plant,equipment ------5K--0--5K----------0--0--0----
Income before tax 53.60%-58K56.51%-254K115.03%26K79.86%-28K13.01%-127K0.79%-125K40.77%-584K38.21%-173K41.84%-139K30.14%-146K
Income tax
Earnings from equity interest net of tax
Net income 53.60%-58K56.51%-254K115.03%26K79.86%-28K13.01%-127K0.79%-125K40.77%-584K38.21%-173K41.84%-139K30.14%-146K
Net income continuous operations 53.60%-58K56.51%-254K115.03%26K79.86%-28K13.01%-127K0.79%-125K40.77%-584K38.21%-173K41.84%-139K30.14%-146K
Noncontrolling interests
Net income attributable to the company 53.60%-58K56.51%-254K115.03%26K79.86%-28K13.01%-127K0.79%-125K40.77%-584K38.21%-173K41.84%-139K30.14%-146K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 53.60%-58K56.51%-254K115.03%26K79.86%-28K13.01%-127K0.79%-125K40.77%-584K38.21%-173K41.84%-139K30.14%-146K
Diluted earnings per share 95.77%-0.00040.00%-0.01-13.66%-0.00879.90%-0.000213.04%-0.0009-986.96%-0.010.00%-0.01-47.99%-0.00741.97%-0.00189.34%-0.0011
Basic earnings per share 95.77%-0.00040.00%-0.01-13.66%-0.00879.90%-0.000213.04%-0.0009-986.96%-0.010.00%-0.01-47.99%-0.00741.97%-0.00189.34%-0.0011
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg